01/14/2026
🚨 Testosterone therapy in women remains one of the most misunderstood and inconsistently applied areas of hormone care. Unlike men, women do not have FDA-approved testosterone products, making dosing strategy and delivery method critical to both safety and effectiveness.
In this video, I review the clinical evidence behind testosterone pellet dosing in women, explain how pellets compare to topical gels, and clarify why outcomes depend far more on dose, pharmacokinetics, and monitoring than on the delivery method itself.
Drawing from published consensus statements, clinical studies, and real-world patient data, I address:
- Why standardized testosterone options exist for men, but not for women
- How testosterone pellets are dosed safely in clinical practice
- What research shows about absorption, variability, and blood levels
- How to interpret testosterone labs in women
- Why precision matters when approved products are unavailable
This discussion is informed by the General Consensus Position Statement on the Use of Testosterone for Women (Climacteric, 2019), which outlines the evidence base, indications, and limitations of testosterone therapy in women.
This is an evidence-based discussion intended for patients and clinicians seeking a clearer, more rigorous understanding of testosterone therapy in women — grounded in physiology, data, and careful dosing rather than assumptions or fear.
💻 Interested in booking an appointment? LINK IN BIO
📚 Get my best-selling book, S*xually Woke: Awaken the Secrets to Your Best S*x Life in Midlife & Beyond: https://amzn.to/3rm47IU
Testosterone therapy in women remains one of the most misunderstood and inconsistently applied areas of hormone care. Unlike men, women do not have FDA-appro...